Scinovex
reviewTop 10% cited

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Psychopharmacology · 2003 · Vol. 169(3-4) · pp. 215–233
John H. KrystalDeepak Cyril D’SouzaDaniel H. MathalonEdward PerryAyşenil BelgerRalph E. Hoffman
Neuroscience and Neuropharmacology ResearchTryptophan and brain disordersTreatment of Major DepressionNMDA receptorGlutamatergicDisinhibitionSchizophrenia (object-oriented programming)NeurosciencePsychologyGlutamate receptorPsychosisAntagonistPhencyclidine

MeSH terms

AnimalsCerebral CortexCognitionHumansKetamineModels, NeurologicalNeural PathwaysSchizophreniaAntipsychotic AgentsReceptors, N-Methyl-D-AspartateExcitatory Amino Acid AntagonistsGlutamic Acid
Citations
531
FWCI
5.78
field-weighted impact
References
308
Percentile
98%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.